Global Bio-chem Technology Group Co. Ltd. (DE:GLY)
FRANKFURT:GLY
Total Valuation
Global Bio-chem Technology Group Co. Ltd. has a market cap or net worth of €109.29M. The enterprise value is €2.23B.
Market Cap€109.29M
Enterprise Value€2.23B
Share Statistics
Global Bio-chem Technology Group Co. Ltd. has 16,832,771,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,832,771,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Global Bio-chem Technology Group Co. Ltd.’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -6.11%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)-6.11%
Return on Capital Employed (ROCE)-1.54
Revenue Per Employee1.45M
Profits Per Employee99.81K
Employee Count1,567
Asset Turnover0.49
Inventory Turnover46.41
Valuation Ratios
The current PE Ratio of Global Bio-chem Technology Group Co. Ltd. is 17.3. Global Bio-chem Technology Group Co. Ltd.’s PEG ratio is -0.13.
PE Ratio17.3
PS Ratio0.74
PB Ratio-3.27
Price to Fair Value-3.27
Price to FCF-59.64
Price to Operating Cash Flow-368.79
PEG Ratio-0.13
Income Statement
In the last 12 months, Global Bio-chem Technology Group Co. Ltd. had revenue of 2.28B and earned 156.30M in profits. Earnings per share was 0.01.
Revenue2.28B
Gross Profit196.44M
Operating Income-78.54M
Pretax Income156.41M
Net Income156.30M
EBITDA-1.89M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was -7.35M and capital expenditures -21.04M, giving a free cash flow of -28.39M billion.
Operating Cash Flow-7.35M
Free Cash Flow-28.39M
Free Cash Flow per Share>-0.01
Dividends & Yields
Global Bio-chem Technology Group Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.73
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)48.13
Average Volume (3m)10.42K
Important Dates
Global Bio-chem Technology Group Co. Ltd. upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Global Bio-chem Technology Group Co. Ltd. as a current ratio of 0.49, with Debt / Equity ratio of -345.90%
Current Ratio0.49
Quick Ratio0.48
Debt to Market Cap1.06
Net Debt to EBITDA-899.47
Interest Coverage Ratio-0.25
Taxes
In the past 12 months, Global Bio-chem Technology Group Co. Ltd. has paid 110.00K in taxes.
Income Tax110.00K
Effective Tax Rate<0.01
Enterprise Valuation
Global Bio-chem Technology Group Co. Ltd. EV to EBITDA ratio is -1.80K, with an EV/FCF ratio of -119.49.
EV to Sales1.49
EV to EBITDA-1.80K
EV to Free Cash Flow-119.49
EV to Operating Cash Flow-461.48
Balance Sheet
Global Bio-chem Technology Group Co. Ltd. has €94.44M in cash and marketable securities with €1.79B in debt, giving a net cash position of -€1.70B billion.
Cash & Marketable Securities€94.44M
Total Debt€1.79B
Net Cash-€1.70B
Net Cash Per Share-€0.10
Tangible Book Value Per Share-€0.02
Margins
Gross margin is 8.62%, with operating margin of -3.45%, and net profit margin of 6.86%.
Gross Margin8.62%
Operating Margin-3.45%
Pretax Margin6.86%
Net Profit Margin6.86%
EBITDA Margin-0.08%
EBIT Margin-4.79%
Analyst Forecast
The average price target for Global Bio-chem Technology Group Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.42%
EPS Growth Forecast-85.44%